Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1314-2026Class II

Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument

Hologic, Inc. / initiated 2025-12-15 / Open, Classified

Hologic, Inc began a recall of Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument on . FDA classified it as Class II and gives the reason as "Presence of particulates in affected devices that can be deposited into breast tissue during use". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1314-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Hologic, Inc.
Product
Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.
Product code
KNW Instrument, Biopsy
Reason for recall
Presence of particulates in affected devices that can be deposited into breast tissue during use.
FDA root cause
Under Investigation by firm
Action
An URGENT FIELD SAFETY NOTICE (REMOVAL) was mailed to consignees on 1/2/26. The notification instructs consignees to quarantine affected devices and return them through IQVIA per the instructions provided on the Recall Response Form. The recall notification should be forwarded within consignee locations to users and to any facility to which product was further distributed. A copy of the recall notification is to be posted for awareness at consignee locations. Questions can be directed to [email protected] or by phone at 1-877-371-4372. An updated FIELD TECHNICAL BULLETIN dated May 2026 was distributed to consignees. This technical bulletin provides guidance to healthcare providers on how to utilize the Brevera Breast Biopsy System without the use of the Brevera 9 Gauge Biopsy Needle. Questions can be directed to [email protected] or by phone at 1-877-371-4372.
Quantity in commerce
681,870 units
Distribution
US Nationwide distribution.
Product codes and lots
Model No - BREVDISP09; UDI - 1540045512863; All Lots within expiry.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1314-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1314-2026Class IIOngoingVoluntary: Firm initiated